Intelligent Relations
Preston by Intelligent Relations
Charles Bankhead
Gray shield icon
Is this you?
Claim your profile.

Charles Bankhead

Staff Writer

AS SEEN ON
MedPage Today

Preston's Summary

Charles Bankhead is a Staff Writer at MedPage Today. He covers a range of topics within medicine and healthcare, focusing on areas such as dermatology, gene therapy, immunotherapy, and oncology, while also exploring themes related to alternative medicine and healthcare technology. Charles has been featured in Knowledia, MDEdge, and MSN, contributing to the ongoing discourse in these vital fields.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Data Driven: 48 %
Informative: 48 %
Interviews Q&as: 1 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Dermatology
  • Gene Therapy
  • Immunotherapy
  • Oncology
  • Pancreatic Cancer Research
  • Radiation Oncology
  • Surgery
  • Mental Health Care

Pitching Insights

Charles Bankhead's focus is primarily on medical research, clinical trials, FDA approvals, and scientific developments in healthcare and pharmaceuticals. His coverage includes citing data from various studies and press releases.

If you are reaching out to Charles, consider providing insights or commentary based on recent medical research findings or clinical trial outcomes. Expert opinions related to FDA approvals, drug therapies, or challenges in specific areas of healthcare could be well-received by him.

Since his geographic focus is not specified but his topics are broad and universal, pitches can come from experts across the globe who have valuable insights into these areas of medical research and pharmaceuticals.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Mike Bassett

Mike Bassett

*******tt@*************com
Publications
MedPage Today
Most recent topics
Not enough data
Mark Leiser

Mark Leiser

Content Strategist
******r@********om
Publications
Healio
Most recent topics
Not enough data
Ian Ingram

Ian Ingram

Deputy Managing Editor
******m@*************com
Publications
MedPage Today
Most recent topics
Not enough data
Vicki Moore

Vicki Moore

Contributing Writer
****i@**************.com
Publications
Cancer Therapy Advisor, Hematology Advisor, Oncology Nurse Advisor, Pulmonology Advisor, Dermatology Advisor
Most recent topics
Not enough data
Leah Lawrence

Leah Lawrence

Journalist
Publications
ashpublications.org, Oncology News Central, MedPage Today
Most recent topics
Not enough data
Heather Biele

Heather Biele

Medical Copy Editor
Publications
Healio
Most recent topics
Not enough data

Articles

MSN

Loss of follow-up predictors in wet AMD

Loss of follow-up predictors in wet AMD

By: Charles Bankhead

A fifth of patients receiving treatment for neovascular (wet) age-related macular degeneration (AMD) stopped care without explanation during long-term follow-up in a large multicenter Canadian cohort.

© 2026 Intelligent Relations